Burning Rock Biotech
BNR
$0.81
Share price
6.38%
Change (1 day)
-72.27%
Change (1 year)
Categories
Operating Margin for Burning Rock Biotech (BNR)
Operating Margin as of May 2024 (TTM): -173.69%
According to Burning Rock Biotech's latest financial reports and stock price the company's current Operating Margin is -173.69%. At the end of 2021 the company had an Operating Margin of -156.70%.
Operating Margin history for Burning Rock Biotech from 2019 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -156.70% | 65.42% |
| 2020 | -94.73% | 113.74% |
| 2019 | -44.32% | -47.85% |
| 2018 | -84.98% | -28.04% |
| 2017 | -118.09% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 LabCorp LH | 10.63% | -106.12% | 🇺🇸 USA |
 OpGen
OPGN | -1,429.94% | 723.27% | 🇺🇸 USA |
 NeoGenomics
NEO | -31.26% | -82.00% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.